
Sign up to save your podcasts
Or


Send us Fan Mail
Welcome to your essential overview of the global biotech and pharmaceutical landscape for April 2026!
This month was dominated by a high-stakes pivot toward oral obesity treatments, a massive consolidation of precision oncology platforms like ADCs and radiopharmaceuticals, and a structural shift toward AI-native drug discovery and in-vivo genomic medicine.
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes!
https://linktr.ee/maneadkhin
#PetriDishPerspectives #BiotechNews #PharmaNews
Support the show
© 2026 The Perspective Bureau LLC. All rights reserved.
By Manead KhinSend us Fan Mail
Welcome to your essential overview of the global biotech and pharmaceutical landscape for April 2026!
This month was dominated by a high-stakes pivot toward oral obesity treatments, a massive consolidation of precision oncology platforms like ADCs and radiopharmaceuticals, and a structural shift toward AI-native drug discovery and in-vivo genomic medicine.
🎧 Listen now, stay curious, and don’t forget to subscribe for new episodes!
https://linktr.ee/maneadkhin
#PetriDishPerspectives #BiotechNews #PharmaNews
Support the show
© 2026 The Perspective Bureau LLC. All rights reserved.